These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 36875095)
41. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420 [TBL] [Abstract][Full Text] [Related]
42. Type II but Not Type I IFN Signaling Is Indispensable for TLR7-Promoted Development of Autoreactive B Cells and Systemic Autoimmunity. Chodisetti SB; Fike AJ; Domeier PP; Singh H; Choi NM; Corradetti C; Kawasawa YI; Cooper TK; Caricchio R; Rahman ZSM J Immunol; 2020 Feb; 204(4):796-809. PubMed ID: 31900342 [TBL] [Abstract][Full Text] [Related]
43. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537 [TBL] [Abstract][Full Text] [Related]
44. Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling. Giltiay NV; Shu GL; Shock A; Clark EA Arthritis Res Ther; 2017 May; 19(1):91. PubMed ID: 28506291 [TBL] [Abstract][Full Text] [Related]
45. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection. Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518 [TBL] [Abstract][Full Text] [Related]
46. Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. Christensen SR; Shlomchik MJ Semin Immunol; 2007 Feb; 19(1):11-23. PubMed ID: 17276080 [TBL] [Abstract][Full Text] [Related]
47. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells. Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778 [TBL] [Abstract][Full Text] [Related]
48. UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus. Mauro D; Manou-Stathopoulou S; Rivellese F; Sciacca E; Goldmann K; Tsang V; Lucey-Clayton I; Pagani S; Alam F; Pyne D; Rajakariar R; Gordon PA; Whiteford J; Bombardieri M; Pitzalis C; Lewis MJ J Autoimmun; 2023 Apr; 136():103023. PubMed ID: 37001433 [TBL] [Abstract][Full Text] [Related]
49. B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice. Cosgrove HA; Gingras S; Kim M; Bastacky S; Tilstra JS; Shlomchik MJ JCI Insight; 2023 Aug; 8(16):. PubMed ID: 37606042 [TBL] [Abstract][Full Text] [Related]
50. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685 [TBL] [Abstract][Full Text] [Related]
51. The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis. Echavarria R; Cardona-Muñoz EG; Ortiz-Lazareno P; Andrade-Sierra J; Gómez-Hermosillo LF; Casillas-Moreno J; Campos-Bayardo TI; Román-Rojas D; García-Sánchez A; Miranda-Díaz AG Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894915 [TBL] [Abstract][Full Text] [Related]
52. Regulation of autoreactive B cell responses to endogenous TLR ligands. Avalos AM; Busconi L; Marshak-Rothstein A Autoimmunity; 2010 Feb; 43(1):76-83. PubMed ID: 20014959 [TBL] [Abstract][Full Text] [Related]
53. Nucleic acid recognition receptors in autoimmunity. Krug A Handb Exp Pharmacol; 2008; (183):129-51. PubMed ID: 18071658 [TBL] [Abstract][Full Text] [Related]
54. Plasma Cell Differentiation Pathways in Systemic Lupus Erythematosus. Malkiel S; Barlev AN; Atisha-Fregoso Y; Suurmond J; Diamond B Front Immunol; 2018; 9():427. PubMed ID: 29556239 [TBL] [Abstract][Full Text] [Related]
55. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11c Yim LY; Lau CS; Chan VS Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546763 [TBL] [Abstract][Full Text] [Related]
56. Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW Clin Exp Immunol; 2010 Jan; 159(1):11-22. PubMed ID: 19843090 [TBL] [Abstract][Full Text] [Related]
57. B Cell αv Integrins Regulate TLR-Driven Autoimmunity. Acharya M; Raso F; Sagadiev S; Gilbertson E; Kadavy L; Li QZ; Yan M; Stuart LM; Hamerman JA; Lacy-Hulbert A J Immunol; 2020 Oct; 205(7):1810-1818. PubMed ID: 32859730 [TBL] [Abstract][Full Text] [Related]
58. Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Klonowska-Szymczyk A; Wolska A; Robak T; Cebula-Obrzut B; Smolewski P; Robak E Mediators Inflamm; 2014; 2014():381418. PubMed ID: 24692849 [TBL] [Abstract][Full Text] [Related]
59. Excessive activation of the TLR9/TGF-β1/PDGF-B pathway in the peripheral blood of patients with systemic lupus erythematosus. Yuan Y; Yang M; Wang K; Sun J; Song L; Diao X; Jiang Z; Cheng G; Wang X Arthritis Res Ther; 2017 Mar; 19(1):70. PubMed ID: 28356164 [TBL] [Abstract][Full Text] [Related]
60. Single nucleotide polymorphisms in genes encoding toll-like receptors 7, 8 and 9 in Danish patients with systemic lupus erythematosus. Enevold C; Nielsen CH; Jacobsen RS; Hermansen ML; Molbo D; Avlund K; Bendtzen K; Jacobsen S Mol Biol Rep; 2014 Sep; 41(9):5755-63. PubMed ID: 24919757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]